Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it.
Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California, San Francisco: Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, as well as renowned biotech executives George Scangos and Norbert Bischofberger. These leaders bring with them a strong track record of amazing discoveries and scientific breakthroughs, leading to very successful companies and many FDA approved drugs.
Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California, San Francisco: Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, as well as renowned biotech executives George Scangos and Norbert Bischofberger. These leaders bring with them a strong track record of amazing discoveries and scientific breakthroughs, leading to very successful companies and many FDA approved drugs.
Location: United States, California, San Francisco
Employees: 1-10
Total raised: $78M
Investors 3
| Date | Name | Website |
| - | Norwest Ve... | nvp.com |
| - | Hawktail M... | hawktail.c... |
| 27.11.2022 | SR One | srone.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.11.2022 | Series A | $78M | a16z |
Mentions in press and media 3
| Date | Title | Description |
| 11.08.2023 | Philanthropic endowments at universities can offer a way out of biotech’s Valley of Death | So many promising medical innovations never reach their full potential as therapies or cures, languishing instead in a metaphoric place many of us in biotech know as “the Valley of Death.” This valley represents the gap between when a scien... |
| 22.11.2022 | Rezo Therapeutics Raises $78M in Series A Funding | Rezo Therapeutics, San Francisco, CA-based biotechnology company, raised $78M in Series A funding. The round was led by SR One, a16z Bio + Health, and Norwest Venture Partners, and also included SV Angel, Liquid 2 Ventures, and Hawktail. Th... |
| - | Rezo Therapeutics | “Rezo is pioneering an integrated approach to drug discovery to enabling the pinpointing of targets and the development of therapies with unprecedented clarity and speed.” |